Skip to main content
. 2021 Jan 21;16:13. doi: 10.1186/s13020-021-00423-4

Fig. 9.

Fig. 9

Proliferative inhibitory effects of five active compounds of YCHD treatment, including quercetin (a), kaempferol (b), beta-sitosterol (c), isorhamnetin (d), and stigmasterol (e) on KKU-M213 cells. Drug concentration-cell viability curves were generated based on the cell viability assay. All data were expressed as mean ± SD